New England Journal of Medicine

Vol. 392, Issue 6 Issue 6 2025
20
Articles

Articles in this Issue

Perioperative Durvalumab in Bladder Cancer

Feb 06, 2025 pp. 618-619 10.1056/nejmc2415733

The Man Who Lives in the Cardboard Box

Teva D. Brender Feb 06, 2025 pp. 528-529 10.1056/nejmp2410139

Pulling Out the Rug on Informed Consent — New Legal Threats to Clinicians and Patients

Kristen Underhill, Kimberly M. Nelson Feb 06, 2025 pp. 523-525 10.1056/nejmp2413570

Childhood Obesity and GLP-1 Receptor Agonists — A Coming of Age?

Timothy Barrett, Julian Hamilton-Shield Feb 06, 2025 pp. 609-611 10.1056/nejme2410560

Amivantamab plus Lazertinib in Previously Untreated <i>EGFR</i> -Mutated Advanced NSCLC

Feb 06, 2025 pp. 619-621 10.1056/nejmc2414705

Lead Poisoning

Feb 06, 2025 pp. 623-624 10.1056/nejmc2415108

Traveling Companions

Rachel K. Gardner, Daniel A. Solomon, Allison S. Bloom et al. Feb 06, 2025 pp. 600-606 10.1056/nejmcps2402893

Cell and Gene Therapies — Improving Access and Outcomes for Medicare and Medicaid Beneficiaries

Joseph S. Ross Feb 06, 2025 pp. 521-523 10.1056/nejmp2412955

Hypothyroid Myopathy with Muscle Pseudohypertrophy

Kajananan Sivagurunathan, Nalayini Jegathesan Feb 06, 2025 pp. 599-599 10.1056/nejmicm2413623

CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in <i>TP53</i>

Karlo Perica, Nayan Jain, Michael Scordo et al. Feb 06, 2025 pp. 577-583 10.1056/nejmoa2411507

<i>Plaques en Prairie Fauchée</i> Tongue Lesions in Secondary Syphilis

Jonathan P. Angel Feb 06, 2025 10.1056/nejmicm2411077

Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy

Vlado Perkovic, Jonathan Barratt, Brad Rovin et al. Feb 06, 2025 pp. 531-543 10.1056/nejmoa2410316

Liraglutide for Children 6 to &lt;12 Years of Age with Obesity — A Randomized Trial

Claudia K. Fox, Margarita Barrientos-Pérez, Eric M. Bomberg et al. Feb 06, 2025 pp. 555-565 10.1056/nejmoa2407379

Atrasentan in Patients with IgA Nephropathy

Hiddo J.L. Heerspink, Meg Jardine, Donald E. Kohan et al. Feb 06, 2025 pp. 544-554 10.1056/nejmoa2409415

Identifying and Targeting TNF Signaling in Idiopathic Multicentric Castleman’s Disease

Melanie D. Mumau, Michael V. Gonzalez, Chunyu Ma et al. Feb 06, 2025 pp. 616-618 10.1056/nejmc2412494

Way Stations in Progress — Burgeoning Treatment Options for IgA Nephropathy

Julie R. Ingelfinger Feb 06, 2025 pp. 608-609 10.1056/nejme2413288

Uterine Fibroids

Feb 06, 2025 pp. 621-622 10.1056/nejmc2415479

Discovery of GLP-1–Based Drugs for the Treatment of Obesity

Daniel J. Drucker Feb 06, 2025 pp. 612-615 10.1056/nejmcibr2409089

Efficacy of Zenocutuzumab in <i>NRG1</i> Fusion–Positive Cancer

Alison M. Schram, Koichi Goto, Dong-Wan Kim et al. Feb 06, 2025 pp. 566-576 10.1056/nejmoa2405008

The Future of Gender-Affirming Care — A Law and Policy Perspective on the Cass Review

Daniel G. Aaron, Craig Konnoth Feb 06, 2025 pp. 526-528 10.1056/nejmp2413747

All Issues

Journal Info

Publisher Massachusetts Medical Society
ISSN 0028-4793
E-ISSN 0096-6762
Subject Social Sciences
Language English
View Full Journal Page